Publication: Daratumumab Plus Bortezomib, Lenalidomide and Dexamethasone for Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma: The Randomized Phase 3 Cepheus Trial
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Basu, Supratik/0000-0003-2206-4796; Bahlis, Nizar/0000-0001-7353-7034; Usmani, Saad/0000-0002-5484-8731
Keywords
Citation
WoS Q
Q1
Scopus Q
Q1
Source
Nature Medicine
Volume
31
Issue
4
Start Page
1366
End Page
1366